Isabelle Lascombe

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

Sylvie Fauconnet, Isabelle Lascombe, É. Chabannes et al. · Journal of Biological Chemistry · 2002 · 110 citations · Full text

Medicine, Molecular Biology, Oncology +17

N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors

Isabelle Lascombe, Anne Clairotte, Sylvie Fauconnet et al. · Clinical Cancer Research · 2006 · 104 citations · Full text

Medicine, Oncology, Pathology +16

A‐FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells

Guillaume Boiteux, Isabelle Lascombe, E de la Roche et al. · International Journal of Cancer · 2008 · 69 citations

Medicine, Molecular Biology, Oncology +17

Expression of E-Cadherin and α-,β-,γ-Catenins in Patients With Bladder Cancer

Anne Clairotte, Isabelle Lascombe, Sylvie Fauconnet et al. · American Journal of Clinical Pathology · 2006 · 59 citations

Medicine, Oncology, Pathology +17

Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogenic compounds.

Isabelle Lascombe, Dominique Beffa, Urs T. Rüegg et al. · Environmental Health Perspectives · 2000 · 56 citations · Full text

Life Sciences, Endocrinology, Toxicology +15